PortViewPortView
Basel Medical logo

Basel Medical (BMGL) Stock Analysis

NASDAQHealthcareMedical - Care Facilities

$5.40+6.30%
1-year price historyRange $4.51 – $24.84
52-week range$5.40
$4.17$25.80

What Basel Medical does

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Key metrics

Market cap
$8.45M
P/E (TTM)
-1.02
EPS (TTM)
$-5.29
Beta
0.24
Dividend yield
0.00%
Revenue / share
$9.13
50-day avg
$5.88
200-day avg
$7.79
52-week high
$25.80
52-week low
$4.17
CEO
Yen Feng Chhoa

ETFs linked to BMGL

Broad-market and Healthcare sector ETFs an investor holding Basel Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BMGL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BMGL in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Basel Medical?
Basel Medical trades under the ticker BMGL on NASDAQ.
Which exchange is BMGL listed on?
BMGL is listed on NASDAQ.
What sector does Basel Medical operate in?
Basel Medical is classified in the Healthcare sector (Medical - Care Facilities industry).
How can PortView help analyze BMGL in a portfolio?
PortView shows BMGL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.